title: Population pharmacokinetic/pharmacodynamic analyses as the basis for dosing of therapeutic monoclonal antibodies.
authors.affiliation: College of Pharmacy, University of Tennessee Health Science Center, Memphis, USA. bmeibohm@uthsc.edu
authors.forename: Bernd
authors.initials: B
authors.lastname: Meibohm
mesh_terms: D000911:Antibodies, Monoclonal / Q000493:pharmacokinetics*; D061067:Antibodies, Monoclonal, Humanized; D050071:Bone Density Conservation Agents / Q000493:pharmacokinetics*; D001851:Bone Diseases, Metabolic / Q000097:blood*; D000069448:Denosumab; D005260:Female; D006801:Humans; D008954:Models, Biological; D010024:Osteoporosis / Q000097:blood*; D053245:RANK Ligand / Q000037:antagonists & inhibitors*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D050071:Bone Density Conservation Agents; D053245:RANK Ligand; D000069448:Denosumab
references.citation: J Pharmacokinet Pharmacodyn. 2008 Oct;35(5):573-91
references.pmid: 19005743
references.citation: J Clin Pharmacol. 2009 Sep;49(9):1012-24
references.pmid: 19620385
references.citation: AAPS J. 2008 Dec;10(4):552-9
references.pmid: 19003542
references.citation: Clin Pharmacokinet. 2011 Dec 1;50(12):793-807
references.pmid: 22087866
references.citation: Clin Pharmacokinet. 2010 Oct;49(10):633-59
references.pmid: 20818831